Last reviewed · How we verify
NCT03919513
Effect of Combined IMT and CPAP in Pulmonary Rehabilitation for COPD
NA trial testing inspiratory pressure threshold device in Pulmonary Rehabilitation in 30 participants. Completed in 1 May 2022.
1 February 2022
Quick facts
| Lead sponsor | Zhujiang Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 1 May 2019 |
| Primary completion | 1 February 2022 |
| Estimated completion | 1 May 2022 |
| Sites | 1 location across China |
Drugs / interventions tested
- inspiratory pressure threshold device
Conditions studied
- Pulmonary Rehabilitation — all drugs for Pulmonary Rehabilitation →
Sponsor
Zhujiang Hospital
Who can join
Adults 40 to 80, any sex, with Pulmonary Rehabilitation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Inspiratory muscle training(IMT) was one of the widely used pulmonary rehabilitation method in COPD patients.However, when the respiratory muscles are fatigue without sufficient rest, IMT may increase muscle fatigue and aggravate muscle damage. Noninvasive positive pressure ventilation (NPPV) is another important strategy of pulmonary rehabilitation which could overcome airway resistance and reduce respiratory work, improve respiratory muscle fatigue. Therefore, the purpose of this study was to explore the effective of the "IMT - NPPV sequential" rehabilitation method, that is, first inspiratory muscle training, followed by respiratory muscle resting (non-invasive positive pressure ventilation).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03919513
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of inspiratory pressure threshold device
Trials testing the same drug.
- NCT03500042 — Effects of Different Modes of Respiratory MuscleTraining on Respiratory Mechanics and NRD in Patient With Stable COPD. · NA · completed
Other recruiting trials for Pulmonary Rehabilitation
Currently open trials in the same condition.
- NCT07430943 — Feasibility of Integrating Street Racket Into Ambulatory Pulmonary Rehabilitation · NA · recruiting
- NCT07185178 — Effect of Video Game-Based Breathing Exercises on Respiratory Dysfunction in ACOS · NA · recruiting
- NCT07061444 — Effects of Different Inspiratory Muscle Training Protocols in Hematopoietic Stem Cell Transplant Recipients · NA · recruiting
- NCT06998550 — Patient Experiences and the Role of Team Structures in Pulmonary Rehabilitation in Türkiye · recruiting
- NCT07195838 — Mindful-Breath for People With COPD · NA · recruiting
Other Zhujiang Hospital trials
Trials by the same sponsor.
- NCT07335094 — A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lym · EARLY_PHASE1 · not yet recruiting
- NCT07469072 — Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in t · Phase 2 · recruiting
- NCT07455149 — An Observational Clinical Study on the Association of Intestinal Ruminococcus Gnavus and Its Derived Biogenic Amines Wit · not yet recruiting
- NCT07457099 — Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral a · not yet recruiting
- NCT07454421 — Racecadotril for Organ Injury in Sepsis Patients · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03919513 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zhujiang Hospital
- Last refreshed: 13 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03919513.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing